Monitor for further dilution risk and potential Nasdaq compliance challenges given the tiny market cap and aggressive capital raise. The lock-up agreements for insiders expire 90 days post-closing, which could lead to additional selling pressure. Evaluate the company's ability to deploy proceeds effectively toward acquisitions or business growth without further dilutive events.
Price Chart
Executive Summary
iSpecimen (ISPC) closed a $5M public offering on August 7, 2026, issuing 996,231 shares of common stock and pre-funded warrants for 2,849,923 additional shares at $1.30 per share (or $1.2999 per warrant). The proceeds will be used for liability repayment, potential acquisitions, marketing, and working capital. This dilutive capital raise comes at a $3M market cap, severely diluting existing common shareholders.
Key Facts
- Public offering raised gross proceeds of approximately $5,000,000 (or $5,000,285 assuming full warrant exercise).
- Offering comprised 996,231 shares of common stock and pre-funded warrants to purchase up to 2,849,923 shares.
- Offering price was $1.30 per share (or $1.2999 per pre-funded warrant).
- The offering closed on August 7, 2026.
- E.F. Hutton & Co. acted as exclusive placement agent, receiving a 4.0% cash fee and a 1% non-accountable expense allowance.
- Proceeds intended for repayment of liabilities, potential acquisitions/marketing, and working capital.
- iSpecimen has a market capitalization of approximately $3M, making this offering highly dilutive relative to existing equity.
Financial Impact
$5,000,000 gross proceeds with severe dilution: ~3M new shares (units) vs likely <10M shares pre-offering at a ~$3M market cap
Risk Factors
- Massive dilution from the offering (nearly tripling share count based on pre-funded warrants vs current market cap).
- Risk of further capital needs if proceeds are burned through quickly.
- Potential Nasdaq delisting if the stock price remains low and market cap fails to recover.
- Use of proceeds for 'potential acquisitions' carries execution risk and may not improve fundamentals.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-086768 |
| Document: ea030100601ex10-1.htm | 0001213900-26-086768 |
| Document: ea030100601ex4-1.htm | 0001213900-26-086768 |
| Document: ea0301006-8k_ispecimen.htm | 0001213900-26-086768 |
| Document: ea030100601ex99-2.htm | 0001213900-26-086768 |
| Document: ea030100601ex99-1.htm | 0001213900-26-086768 |
| Document: 0001213900-26-086768-index-headers.html | 0001213900-26-086768 |
| Document: 0001213900-26-086768-index.html | 0001213900-26-086768 |
| Document: 0001213900-26-086768.txt | 0001213900-26-086768 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 6w ago | 8-K | $1.47 | awaiting T+60 | — | $0.8400 (+42.86%) |
Sep 4, 2026 7w ago | 8-K | $1.59 | awaiting T+60 | — | $0.8400 (−47.17%) |
Aug 14, 2026 10w ago | 8-K | $2.15 | awaiting T+60 | — | $0.8400 (+60.93%) |
Aug 7, 2026 11w ago | 8-K | $2.24 | awaiting T+60 | — | $0.8400 (+62.50%) |
Aug 7, 2026 11w ago | 424B4 | $2.22 | awaiting T+60 | — | $0.8400 (+62.16%) |
Jul 31, 2026 12w ago | EFFECT | $1.89 $0.8398 | ▲ +55.57% | ▲ +58.02% | $0.8400 (+55.56%) |
Jul 16, 2026 14w ago | S-1/A | $2.10 $1.08 | ▲ +48.57% | ▲ +53.25% | $0.8400 (+60.00%) |
Jul 14, 2026 14w ago | 8-K | $2.23 $1.09 | ▼ −51.12% | ▼ −53.65% | $0.8400 (−62.33%) |
Jun 18, 2026 18w ago | EFFECT | $2.59 $1.47 | ▲ +43.24% | ▲ +45.14% | $0.8400 (+67.57%) |
Jun 1, 2026 21w ago | 8-K | $3.07 $1.64 | ▲ +46.58% | ▲ +47.70% | $0.8400 (+72.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers